207940:KRX
Samsung Biologics Co Ltd
â‚©1,415,000.00
arrow_downward
-0.56%(-8,000.00) 1D
Sep 11, 3:30:18 PM GMT+9 · KRW
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
â‚©1,406,000
High
â‚©1,423,000
Low
â‚©1,396,000
Mkt. cap
65.50T
Avg. vol.
50.15K
Volume
0.00
P/E ratio
30.59
52-wk high
â‚©1,987,000
52-wk low
â‚©982,000
EPS
â‚©46,253
Shares outstanding
46.29M
No. of employees
5K
Open
â‚©1,406,000
High
â‚©1,423,000
Low
â‚©1,396,000
Mkt. cap
65.50T
Avg. vol.
50.15K
Volume
0.00
P/E ratio
30.59
52-wk high
â‚©1,987,000
52-wk low
â‚©982,000
EPS
â‚©46,253
Shares outstanding
46.29M
No. of employees
5K
News stories
From web sources and news partners
BioPharm International
·
1 day ago
Samsung Biologics Signs $262M Biologics Manufacturing Deal With Undisclosed European Pharma Company
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd